Labeler · US market
Novo Nordisk A/S
Novo Nordisk A/S is a US drug labeler with US FDA registrations covering 10 drug concepts (10 currently active) across 26 packages. It is currently the only active US supplier of 6 drugs.
ACTIVE — US
openFDA · updated weekly
Labeler codes0420
Active drugs10
Registrations22 active / 22
Packages26
Sole supplier of6 drugs
Portfolio10 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Semaglutide injection, solution | rx | 7 | 7 | SUPPLYING |
| Benzalkonium Chloride solution | other | 1 | 4 | SUPPLYING |
| Semaglutide Snac tablet | other | 3 | 3 | SUPPLYING |
| Insulin Recombinant Human crystal | other | 2 | 2 | SUPPLYING |
| Semaglutide powder | other | 2 | 2 | SUPPLYING |
| Benzalkonium Chloride gel | other | 1 | 2 | SUPPLYING |
| Insulin Aspart crystal | other | 2 | 2 | SUPPLYING |
| Insulin Detemir crystal | other | 2 | 2 | SUPPLYING |
| Liraglutide powder | other | 1 | 1 | SUPPLYING |
| Degludec powder | other | 1 | 1 | SUPPLYING |
Pill